Magna pars studiorum, prodita quaerimus. Phasellus laoreet lorem vel dolor tempus vehicula. Nec dubitamus multa iter quae et nos invenerat. Quisque placerat facilisis egestas cillum dolore.
Quisque ut dolor gravida, placerat libero vel, euismod. Quae vero auctorem tractata ab fiducia dicuntur.
SABCS 2021: Understanding and Applying Liquid Biopsies
Learn More
Cancer “Big Data” Buzz in San Francisco
Learn More
AACR Virtual Annual Meeting I: Results on a Targeted Therapeutic for Lung Cancer Support FDA Approval
Learn More
Talking Tamales: A Culturally Tailored Health Education Strategy
Learn More
Hyperglycemia and Aggressive Prostate Cancer Risk
Learn More
AACR COVID-19 and Cancer Virtual Meeting: Tracking the Evolution and Spread of SARS-CoV-2
Learn More
Editors’ Picks: Highlights from AACR Journals
Learn More
Groundbreaking Cancer Immunotherapeutic Approved by FDA
Learn More
Investigational Combination Therapies Improve Responses to Immunotherapy
Learn MoreJune Is Cancer Immunotherapy Month
Learn MoreWe have made spectacular progress against cancer thanks to breakthroughs in cancer science. However, with more than 600,000 people in the United States projected to die from cancer this year, our work is not done. Get involved to ensure that the momentum continues: